By Zheng Qi 2020-07-05

In the Greater Mekong Subregion (GMS), where overlapping threats of artemisinin partial resistance and partner drug resistance once threatened to unravel decades of hard-won progress against malaria, the coordinated public health response has centered on two core, mutually reinforcing pillars: drastically improved, real-time monitoring of drug efficacy and evolving parasite resistance patterns, and an ambitious, region-wide push toward full malaria elimination rather than just routine disease control. This approach marked a deliberate shift from older, traditional malaria management models, recognizing that fragmented, country-only efforts would never be enough to stop resistant parasites from crossing porous borders, spreading across remote forested areas, and undermining local treatment gains. Every step of this response has been rooted in the latest surveillance data, with teams working to map resistance hotspots, track human mobility across national boundaries, and target interventions to the exact communities where residual malaria transmission persists.

Working in close, long-term collaboration with national malaria programmes across all six GMS nations and a wide network of global, regional, and local partners, WHO led the development of the landmark Strategy for Malaria Elimination in the Greater Mekong Subregion (2015–2030). This subregional framework was not a one-size-fits-all document drafted in a distant office; it was co-designed with frontline health workers, national health leaders, and community representatives, tailored to address the unique challenges of the region: cross-border population movement, remote forested transmission sites, scattered ethnic minority communities with limited access to formal health services, and the growing threat of drug-resistant parasites. Under the clear, actionable technical guidance set by WHO in this shared strategy, every single GMS country went on to develop its own detailed national malaria elimination plan, fully aligned with the shared subregional goals while adapted to fit local health system capacities, geographic conditions, and specific epidemiological contexts. As each country rolls out these national plans — deploying mass screening campaigns, distributing long-lasting insecticidal nets, training community health volunteers, and rolling out targeted treatment for residual cases — WHO provides continuous, on-demand technical support through its five dedicated GMS country offices, its regional offices in New Delhi and Manila, and the Organization’s global headquarters in Geneva, ensuring no nation lacks the expertise or resources to keep elimination efforts on track.

To further strengthen this coordinated work and break down long-standing barriers between separate national programs, WHO took an unprecedented step in 2017 by launching the Mekong Malaria Elimination (MME) programme, a dedicated subregional initiative with its core team based in Phnom Penh, Cambodia. Unlike traditional top-down public health projects, the MME team operates as a neutral, collaborative bridge between all stakeholders: it facilitates regular, high-level coordination and open dialogue between national malaria control leaders, donor organizations, academic research teams, and local non-governmental groups, ensuring no two partners duplicate efforts or work at cross purposes. It also manages clear, consistent communication with external global stakeholders, sharing real-time progress updates, resistance alerts, and success stories to keep global attention and funding focused on the region’s elimination goals. Most critically, the MME team leads and coordinates cross-border initiatives that no single country could run on its own, including joint mobile malaria clinics for cross-border migrant workers, synchronized cross-border bed net distribution campaigns, and shared surveillance systems that track resistant parasite strains as they move across national boundaries. Thanks to this years-long, highly coordinated effort, the GMS has made truly impressive, historic progress toward eliminating Plasmodium falciparum — the deadliest malaria parasite species — from the entire subregion, cutting local malaria cases by more than 90% in many areas and pushing the once-distant goal of a malaria-free Mekong firmly within reach.

Edited by: Secretariat of the Asia-Pacific Network for Drug and Diagnostics Innovation
Produced by: Zheng Qi
Reviewed by: Zhang Haobing
Tel: 021-64377008-2510 Fax: 021-54108329
Address: 207 Ruijin 2nd Road, Huangpu District,Shanghai, P.R. China  Postcode: 200025